Ngā hua rapu kaituhi

1

High-Sensitivity C-Reactive Protein: A Novel and Promising Marker of Coronary Heart Disease mā Nader Rifai, Paul M. Ridker

I whakaputaina 2001

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Population Distributions of C-reactive Protein in Apparently Healthy Men and Women in the United States: Implication for Clinical Interpretation mā Nader Rifai, Paul M. Ridker

I whakaputaina 2003

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Proposed Cardiovascular Risk Assessment Algorithm Using High-Sensitivity C-Reactive Protein and Lipid Screening mā Nader Rifai, Paul M. Ridker

I whakaputaina 2001

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Preanalytic and Analytic Sources of Variations in C-reactive Protein Measurement: Implications for Cardiovascular Disease Risk Assessment mā Thomas B. Ledue, Nader Rifai

I whakaputaina 2003

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Methods for Measurement of LDL-Cholesterol: A Critical Assessment of Direct Measurement by Homogeneous Assays versus Calculation mā Matthias Nauck, G. Russell Warnick, Nader Rifai

I whakaputaina 2002

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Evolution of Methods for Measurement of HDL-Cholesterol: From Ultracentrifugation to Homogeneous Assays mā G. Russell Warnick, Matthias Nauck, Nader Rifai

I whakaputaina 2001

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Soluble P-Selectin and the Risk of Future Cardiovascular Events mā Paul M. Ridker, Julie E. Buring, Nader Rifai

I whakaputaina 2001

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Rapid Reduction in C-Reactive Protein With Cerivastatin Among 785 Patients With Primary Hypercholesterolemia mā Paul M. Ridker, Nader Rifai, Susan Pitman Lowenthal

I whakaputaina 2001

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Soluble Intercellular Adhesion Molecule-1, Soluble Vascular Adhesion Molecule-1, and the Development of Symptomatic Peripheral Arterial Disease in Men mā Aruna D. Pradhan, Nader Rifai, Paul M. Ridker

I whakaputaina 2002

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Clinical Efficacy of an Automated High-Sensitivity C-Reactive Protein Assay mā Nader Rifai, Russell P. Tracy, Paul M. Ridker

I whakaputaina 1999

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Comparison of LDL Cholesterol Concentrations by Friedewald Calculation and Direct Measurement in Relation to Cardiovascular Events in 27 331 Women mā Samia Mora, Nader Rifai, Julie E. Buring, Paul M. Ridker

I whakaputaina 2009

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Valsartan, Blood Pressure Reduction, and C-Reactive Protein mā Paul M. Ridker, Eleanor Danielson, Nader Rifai, Robert J. Glynn

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events mā Samia Mora, Nader Rifai, Julie E. Buring, Paul M. Ridker

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Analytical and clinical performance of a homogeneous enzymatic LDL-cholesterol assay compared with the ultracentrifugation-dextran sulfate-Mg2+ method mā Nader Rifai, Elizabeth Iannotti, Kristen M. DeAngelis, Terence Law

I whakaputaina 1998

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Additive Value of Immunoassay-Measured Fibrinogen and High-Sensitivity C-Reactive Protein Levels for Predicting Incident Cardiovascular Events mā Samia Mora, Nader Rifai, Julie E. Buring, Paul M. Ridker

I whakaputaina 2006

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Blood Pressure and Inflammation in Apparently Healthy Men mā Claudia U. Chae, Richard Lee, Nader Rifai, Paul M. Ridker

I whakaputaina 2001

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Plasma proprotein convertase subtilisin/kexin type 9 levels and the risk of first cardiovascular events mā Paul M. Ridker, Nader Rifai, Gary Bradwin, Lynda M. Rose

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Hemoglobin A1c Predicts Diabetes but Not Cardiovascular Disease in Nondiabetic Women mā Aruna D. Pradhan, Nader Rifai, Julie E. Buring, Paul M. Ridker

I whakaputaina 2007

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women mā Paul M. Ridker, Charles H. Hennekens, Julie E. Buring, Nader Rifai

I whakaputaina 2000

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men mā Paul M. Ridker, Nader Rifai, Meir J. Stampfer, Charles H. Hennekens

I whakaputaina 2000

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Nader Rifai

High-Sensitivity C-Reactive Protein: A Novel and Promising Marker of Coronary Heart Disease mā Nader Rifai, Paul M. Ridker

Population Distributions of C-reactive Protein in Apparently Healthy Men and Women in the United States: Implication for Clinical Interpretation mā Nader Rifai, Paul M. Ridker

Proposed Cardiovascular Risk Assessment Algorithm Using High-Sensitivity C-Reactive Protein and Lipid Screening mā Nader Rifai, Paul M. Ridker

Preanalytic and Analytic Sources of Variations in C-reactive Protein Measurement: Implications for Cardiovascular Disease Risk Assessment mā Thomas B. Ledue, Nader Rifai

Methods for Measurement of LDL-Cholesterol: A Critical Assessment of Direct Measurement by Homogeneous Assays versus Calculation mā Matthias Nauck, G. Russell Warnick, Nader Rifai

Evolution of Methods for Measurement of HDL-Cholesterol: From Ultracentrifugation to Homogeneous Assays mā G. Russell Warnick, Matthias Nauck, Nader Rifai

Soluble P-Selectin and the Risk of Future Cardiovascular Events mā Paul M. Ridker, Julie E. Buring, Nader Rifai

Rapid Reduction in C-Reactive Protein With Cerivastatin Among 785 Patients With Primary Hypercholesterolemia mā Paul M. Ridker, Nader Rifai, Susan Pitman Lowenthal

Soluble Intercellular Adhesion Molecule-1, Soluble Vascular Adhesion Molecule-1, and the Development of Symptomatic Peripheral Arterial Disease in Men mā Aruna D. Pradhan, Nader Rifai, Paul M. Ridker

Clinical Efficacy of an Automated High-Sensitivity C-Reactive Protein Assay mā Nader Rifai, Russell P. Tracy, Paul M. Ridker

Comparison of LDL Cholesterol Concentrations by Friedewald Calculation and Direct Measurement in Relation to Cardiovascular Events in 27 331 Women mā Samia Mora, Nader Rifai, Julie E. Buring, Paul M. Ridker

Valsartan, Blood Pressure Reduction, and C-Reactive Protein mā Paul M. Ridker, Eleanor Danielson, Nader Rifai, Robert J. Glynn

Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events mā Samia Mora, Nader Rifai, Julie E. Buring, Paul M. Ridker

Analytical and clinical performance of a homogeneous enzymatic LDL-cholesterol assay compared with the ultracentrifugation-dextran sulfate-Mg2+ method mā Nader Rifai, Elizabeth Iannotti, Kristen M. DeAngelis, Terence Law

Additive Value of Immunoassay-Measured Fibrinogen and High-Sensitivity C-Reactive Protein Levels for Predicting Incident Cardiovascular Events mā Samia Mora, Nader Rifai, Julie E. Buring, Paul M. Ridker

Blood Pressure and Inflammation in Apparently Healthy Men mā Claudia U. Chae, Richard Lee, Nader Rifai, Paul M. Ridker

Plasma proprotein convertase subtilisin/kexin type 9 levels and the risk of first cardiovascular events mā Paul M. Ridker, Nader Rifai, Gary Bradwin, Lynda M. Rose

Hemoglobin A1c Predicts Diabetes but Not Cardiovascular Disease in Nondiabetic Women mā Aruna D. Pradhan, Nader Rifai, Julie E. Buring, Paul M. Ridker

C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women mā Paul M. Ridker, Charles H. Hennekens, Julie E. Buring, Nader Rifai

Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men mā Paul M. Ridker, Nader Rifai, Meir J. Stampfer, Charles H. Hennekens

Ngā utauta rapu:

Ngā marau whai pānga